Cvrx, inc.CVRX.US Overview
US StockHealthcare
(No presentation for CVRX)
CVRX Overall Performance
CVRX AI Analysis & Strategy
CVRX Recent Performance
5.76%
Cvrx, inc.
0.81%
Avg of Sector
-1.14%
S&P500
CVRX PowerScanner
CVRX Key Information
CVRX Valuation Metrics
CVRX Earnings Table
CVRX Profile
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.